Tocilizumab versus anakinra in COVID-19: results from propensity score matching.
Arcani R, Correard F, Suchon P, Kaplanski G, Jean R, Cauchois R, Leprince M, Arcani V, Seguier J, De Sainte Marie B, Andre B, Koubi M, Rossi P, Gayet S, Gobin N, Garrido V, Weiland J, Jouve E, Couderc AL, Villani P, Daumas A.
Arcani R, et al.
Front Immunol. 2023 May 26;14:1185716. doi: 10.3389/fimmu.2023.1185716. eCollection 2023.
Front Immunol. 2023.
PMID: 37304271
Free PMC article.